Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
John Zajicek(Peninsula College of Medicine and Dentistry), Alan J. Thompson(Queen Mary University of London), Andrew Nunn(MRC Clinical Trials Unit at UCL), Jane Vickery(Peninsula College of Medicine and Dentistry), Patrick J. Fox(Fermi National Accelerator Laboratory), D. Wright(University of Exeter), Hilary Sanders(University of Plymouth)
Cited by 828
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k